Distributions of all expression values and Top 1% of expressed Intron features for libraries: Frontal_mRNA, Amygdala_mRNA, Frontal_Ribo, Amygdala_Ribo, Frontal_Ampl, Amygdala_Ampl
Download data matrix file (Intron x library): IntronExpression_v57.txt.gz
Distribution of log2 expression values for library: Frontal_mRNA and data type: Intron
Distribution of all expression values for the feature type: Intron. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Distribution of log2 expression values for library: Amygdala_mRNA and data type: Intron
Distribution of all expression values for the feature type: Intron. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Distribution of log2 expression values for library: Frontal_Ribo and data type: Intron
Distribution of all expression values for the feature type: Intron. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Distribution of log2 expression values for library: Amygdala_Ribo and data type: Intron
Distribution of all expression values for the feature type: Intron. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Distribution of log2 expression values for library: Frontal_Ampl and data type: Intron
Distribution of all expression values for the feature type: Intron. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Distribution of log2 expression values for library: Amygdala_Ampl and data type: Intron
Distribution of all expression values for the feature type: Intron. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Top 1% of expressed Intron features
The following table provides a ranked list of the most highly expressed Intron features. Each column corresponds to an expression library. Each table cell contains the Gene Name (which links to the ALEXA-Seq gene record), followed by the Feature Name (which links to the feature's coordinates in the UCSC Genome Browser and displays expression data), the log2 expression value 'Exp' for the feature, and the percent expression value '% Exp' ([feature expression/gene expression]*100). For Gene records the percent displayed here represents the percentage of all reads for the library instead. Features that are NOT supported by an EST/mRNA sequence are indicated in bold. For exon junction features the number of exons skipped by the junction is indicated as 'Sn', where n is the number of exons skipped (e.g. S0 means no exons skipped, S1 means one exon skipped, etc.).
| RANK | Frontal_mRNA (Gene | Feature | Exp | % Exp) | Amygdala_mRNA (Gene | Feature | Exp | % Exp) | Frontal_Ribo (Gene | Feature | Exp | % Exp) | Amygdala_Ribo (Gene | Feature | Exp | % Exp) | Frontal_Ampl (Gene | Feature | Exp | % Exp) | Amygdala_Ampl (Gene | Feature | Exp | % Exp) |
| 1 | RP5-857K21.2 | I5 | 12.11 | 178650.44% | RP5-857K21.2 | I5 | 12.80 | 1095626.95% | AC012652.3 AC012652.5 | Ix | 8.08 | 151.04% | RP5-857K21.2 | I5 | 9.03 | 14963.03% | PAFAH1B2 | I6 | 9.73 | 12832.17% | MEG3 | I5 | 11.53 | 358.55% |
| 2 | MEG3 | I5 | 11.45 | 325.09% | RP5-857K21.2 | I5 | 12.20 | 722824.73% | KCNC2 | I6 | 7.86 | 245.83% | RP5-857K21.2 | I5 | 8.73 | 12161.20% | RP5-857K21.2 | I5 | 9.72 | 21168.16% | RP5-857K21.2 | I5 | 10.21 | 40813.53% |
| 3 | RP5-857K21.2 | I5 | 11.32 | 103658.95% | MEG3 | I5 | 10.11 | 403.86% | MEG3 | I5 | 7.86 | 120.42% | DHFR | I2 | 8.40 | 2122.91% | MEG3 AL117190.2 | Ix | 9.59 | 96.35% | NAP1L1 | I13 | 9.63 | 49.12% |
| 4 | MEG3 AL117190.2 | Ix | 10.00 | 118.73% | RP4-758J18.6 | I1 | 9.14 | 155.55% | DHFR | I2 | 7.81 | 1382.94% | MEG3 | I5 | 7.97 | 219.10% | HNRPDL | I7 | 9.22 | 87.12% | PAFAH1B2 | I6 | 9.57 | 20887.20% |
| 5 | AC012652.3 AC012652.5 | Ix | 8.93 | 317.21% | PTGDS | I1 | 9.10 | 37.02% | MEG3 | I5 | 7.76 | 112.34% | MEG3 | I5 | 7.13 | 122.29% | TROVE2 | I10 | 9.10 | 514.00% | MAP7 | I2 | 9.41 | 192.90% |
| 6 | MEG3 | I5 | 8.80 | 51.51% | MEG3 AL117190.2 | Ix | 8.73 | 154.62% | SFRS5 | I5 | 7.57 | 77.08% | RP3-518E13.1 | I2 | 6.79 | 1417.95% | MLL5 | I25 | 9.10 | 198.74% | MLL5 | I25 | 9.40 | 210.89% |
| 7 | PNMAL2 | I2 | 8.77 | 312.36% | IGSF8 | I4 | 8.12 | 81.03% | RP5-857K21.2 | I5 | 7.38 | 2317.42% | AC012652.3 AC012652.5 | Ix | 6.68 | 166.42% | NOL7 | I7 | 9.04 | 164.32% | TROVE2 | I10 | 8.77 | 522.04% |
| 8 | DNM1 | I26 | 8.70 | 46.09% | SNRNP70 | I8 | 7.94 | 53.13% | GRIA2 | I14 | 7.19 | 43.78% | SFRS5 | I5 | 6.65 | 77.39% | MEG3 | I5 | 9.02 | 64.93% | ANKRD13A | I9 | 8.67 | 684.87% |
| 9 | SNRNP70 | I8 | 8.62 | 66.96% | IGSF8 | I6 | 7.92 | 70.34% | KCNA2 | I5 | 7.04 | 99.56% | KCNC2 | I6 | 6.47 | 208.66% | SHC4 | I4 | 8.92 | 1575.52% | AC138409.3 | I7 | 8.47 | 212.51% |
| 10 | C14orf45 | I18 | 8.46 | 2742.11% | IGSF8 | I5 | 7.75 | 62.52% | KCNC2 | I5 | 6.98 | 132.91% | MOG | I7 | 6.17 | 103.68% | ANKRD13A | I9 | 8.91 | 922.64% | CCDC65 | I8 | 8.21 | 5178.99% |
| 11 | RUNDC3A | I11 | 8.44 | 35.24% | PAFAH1B2 | I6 | 7.60 | 307.53% | GRIA2 | I9 | 6.92 | 36.15% | RPS20 | I4 | 6.08 | 20.05% | AC012652.3 AC012652.5 | Ix | 8.78 | 102.96% | NOL7 | I7 | 8.11 | 138.54% |
| 12 | HNRPDL | I7 | 8.30 | 100.58% | BRUNOL5 | I12 | 7.47 | 104.19% | TRIM9 | I7 | 6.91 | 114.83% | PAFAH1B2 | I6 | 6.04 | 93.61% | RP11-397O8.2 | I2 | 8.76 | 4645.71% | RP11-404G16.2 TF | Ix | 8.04 | 83.86% |
| 13 | ACADVL | I10 | 8.29 | 63.94% | TROVE2 | I10 | 7.39 | 693.22% | SNURF SNRPN | Ix | 6.88 | 45.94% | RP1-177G6.1 | I3 | 6.00 | 65.56% | NAP1L1 | I13 | 8.74 | 45.85% | FNBP4 | I12 | 8.02 | 345.51% |
| 14 | CUGBP1 | I15 | 8.25 | 773.40% | GNAO1 | I8 | 7.38 | 26.24% | HNRPDL | I7 | 6.83 | 73.26% | ZDHHC11B ZDHHC11 | Ix | 5.82 | 113.95% | C14orf45 | I17 | 8.72 | 2776.04% | RP5-857K21.2 | I5 | 7.94 | 8437.21% |
| 15 | TROVE2 | I10 | 8.23 | 778.95% | HNRPDL | I7 | 7.25 | 73.86% | TPM1 | I14 | 6.75 | 199.49% | SFPQ | I10 | 5.81 | 89.23% | GRIA2 | I15 | 8.71 | 43.95% | MEG3 AL117190.2 | Ix | 7.90 | 28.93% |
| 16 | GRIN1 | I18 | 8.20 | 39.89% | GRIN1 | I18 | 7.22 | 65.40% | DDX5 | I12 | 6.75 | 26.11% | SNORD115-26 UBE3A | Ix | 5.80 | 82.96% | C2orf86 MDH1 | Ix | 8.68 | 44.39% | HNRPDL | I7 | 7.89 | 41.76% |
| 17 | BRUNOL5 | I12 | 8.15 | 72.67% | RUNDC3A | I11 | 7.20 | 33.30% | CDKL5 | I20 | 6.73 | 71.67% | SNORD115-26 UBE3A | Ix | 5.79 | 82.33% | STRBP | I25 | 8.65 | 448.33% | DIMT1L | I11 | 7.88 | 134.91% |
| 18 | PTGDS | I1 | 8.06 | 26.48% | UBE2H | I10 | 7.17 | 424.75% | AAK1 | I23 | 6.73 | 186.02% | SFRS11 | I4 | 5.78 | 101.54% | FNBP4 | I12 | 8.65 | 315.23% | RP4-758J18.6 | I1 | 7.87 | 125.83% |
| 19 | ACBD7 | I6 | 7.88 | 87.34% | ATPGD1 PPP1CA | Ix | 7.09 | 39.39% | ZNF483 | I6 | 6.67 | 40.58% | PXK | I20 | 5.77 | 65.80% | CCDC65 | I8 | 8.54 | 1770.14% | TCP11L1 | I11 | 7.86 | 3456.23% |
| 20 | RP1-177G6.1 | I3 | 7.86 | 65.81% | DHFR | I2 | 7.01 | 210.58% | C14orf45 | I18 | 6.66 | 1348.62% | DDX5 | I12 | 5.72 | 20.67% | C16orf52 | I4 | 8.42 | 469.68% | C14orf45 | I17 | 7.75 | 3243.16% |
| 21 | PAFAH1B2 | I6 | 7.84 | 368.12% | CUGBP1 | I15 | 6.95 | 360.55% | SFPQ | I10 | 6.66 | 129.17% | CHD8 | I2 | 5.71 | 168.96% | PDE4DIP | I6 | 8.37 | 594.34% | AC010542.1 CMTM1 | Ix | 7.72 | 10344.45% |
| 22 | ACADVL | I9 | 7.81 | 46.00% | GP1BB AC000086.1 SEPT5 | Ix | 6.93 | 51.88% | RP11-316C12.1 | I2 | 6.65 | 4279.19% | DIMT1L | I11 | 5.70 | 135.28% | ZRANB2 | I8 | 8.26 | 297.53% | NBPF1 | I7 | 7.71 | 898.80% |
| 23 | SFRS5 | I5 | 7.78 | 34.11% | DNM1 | I26 | 6.93 | 63.80% | SNRPN | I16 | 6.62 | 38.19% | DDX5 | I11 | 5.70 | 20.37% | NBPF1 | I7 | 8.23 | 1547.69% | PRMT2 | I9 | 7.55 | 219.84% |
| 24 | C14orf45 | I17 | 7.68 | 1587.68% | KHSRP | I20 | 6.91 | 125.33% | PAFAH1B2 | I6 | 6.62 | 98.01% | RP4-758J18.6 | I1 | 5.63 | 326.19% | COPG2 | I10 | 8.22 | 90.01% | SATL1 | I5 | 7.52 | 6183.18% |
| 25 | DDX5 | I12 | 7.67 | 31.74% | AC012652.3 AC012652.5 | Ix | 6.89 | 167.39% | COPG2 | I12 | 6.60 | 76.16% | SRPK2 | I29 | 5.61 | 79.86% | MAP2 | I11 | 8.20 | 43.38% | UBE2H | I10 | 7.51 | 88.26% |
| 26 | IGSF8 | I5 | 7.62 | 39.44% | ACADVL | I10 | 6.89 | 39.54% | SNORD115-26 UBE3A | Ix | 6.58 | 69.24% | RALGAPA1 | I18 | 5.60 | 121.52% | SATL1 | I5 | 8.15 | 4124.31% | SLC44A1 | I19 | 7.51 | 53.27% |
| 27 | AC005037.5 AC005037.9 | Ix | 7.62 | 891.67% | BAIAP2 | I16 | 6.88 | 73.73% | AC090510.2 | I2 | 6.58 | 198.36% | TPM1 | I14 | 5.59 | 158.29% | CABP1 | I1 | 8.09 | 357.95% | ZRANB2 | I8 | 7.45 | 214.67% |
| 28 | C14orf153 | I23 | 7.60 | 56.10% | SFRS5 | I5 | 6.83 | 32.81% | AC007254.1 | I5 | 6.58 | 393.83% | H2AFV | I5 | 5.59 | 119.17% | AC068587.3 | I2 | 8.09 | 231.24% | GRIA2 | I13 | 7.35 | 49.78% |
| 29 | RP4-758J18.6 | I1 | 7.60 | 211.86% | BAIAP2 | I15 | 6.83 | 71.19% | TRIM9 | I10 | 6.52 | 87.44% | CUGBP1 | I15 | 5.59 | 133.55% | CUGBP2 | I6 | 8.08 | 37.94% | PDE4DIP | I6 | 7.31 | 517.45% |
| 30 | DGKZ | I29 | 7.58 | 45.77% | DIMT1L | I11 | 6.83 | 208.11% | RPS20 | I4 | 6.51 | 28.62% | TRIM9 | I7 | 5.58 | 91.49% | FIP1L1 | I18 | 8.02 | 539.24% | KLHL5 | I12 | 7.29 | 72.57% |
| 31 | LPCAT4 | I12 | 7.57 | 52.76% | AL592300.3 | I1 | 6.81 | 115.28% | RP3-518E13.1 | I2 | 6.47 | 1248.81% | HNRPDL | I7 | 5.53 | 47.19% | C14orf153 | I23 | 7.97 | 43.99% | SGMS2 AC096564.3 | Ix | 7.26 | 1958.50% |
| 32 | CD3EAP | I2 | 7.48 | 519.10% | ATPGD1 | I8 | 6.79 | 32.09% | ARHGAP21 | I26 | 6.46 | 37.29% | ZC3H11A | I2 | 5.53 | 83.75% | SFRS5 | I5 | 7.96 | 21.37% | TPP1 | I7 | 7.23 | 311.92% |
| 33 | UBE2H | I10 | 7.47 | 384.13% | IGSF8 | I7 | 6.78 | 31.71% | ANKRD36B | I41 | 6.41 | 148.58% | RP11-154D6.1 | I4 | 5.51 | 382.45% | GTPBP8 C3orf17 | Ix | 7.92 | 408.10% | NPC1 | I24 | 7.21 | 156.76% |
| 34 | HSF4 | I14 | 7.40 | 185.78% | PNMAL2 | I2 | 6.77 | 234.90% | PSIP1 | I12 | 6.39 | 70.82% | CDKL5 | I20 | 5.50 | 59.60% | AC010542.1 CMTM1 | Ix | 7.88 | 5393.65% | AC068587.3 | I2 | 7.19 | 154.70% |
| 35 | PSIP1 | I12 | 7.34 | 61.63% | NFASC | I32 | 6.77 | 78.77% | TARBP1 | I23 | 6.39 | 113.04% | C14orf45 | I18 | 5.48 | 951.43% | UBE2H | I10 | 7.86 | 139.02% | COMMD7 | I8 | 7.19 | 100.99% |
| 36 | KHSRP | I20 | 7.34 | 127.75% | IFIT3 LIPA | Ix | 6.76 | 165.94% | SEPT11 | I9 | 6.38 | 66.97% | TRIM2 | I11 | 5.48 | 21.29% | AC068587.3 | I5 | 7.85 | 196.09% | SRPK2 | I29 | 7.16 | 55.17% |
| 37 | EVL | I12 | 7.30 | 20.73% | NFASC | I34 | 6.56 | 67.89% | SNORD115-26 UBE3A | Ix | 6.37 | 59.87% | ACADVL | I9 | 5.47 | 106.40% | PAPOLA | I11 | 7.85 | 220.73% | GSTA4 | I5 | 7.14 | 104.27% |
| 38 | SPTAN1 | I52 | 7.29 | 29.42% | ATPGD1 PPP1CA | Ix | 6.55 | 26.96% | SFRS11 | I4 | 6.34 | 111.77% | SLC6A1 AC024910.1 | Ix | 5.46 | 34.80% | ZNF493 | I2 | 7.83 | 1737.95% | PAPOLA | I11 | 7.12 | 158.87% |
| 39 | ADD2 | I24 | 7.28 | 631.30% | DDX5 | I11 | 6.54 | 23.27% | CUGBP1 | I15 | 6.33 | 131.40% | SEPT11 | I9 | 5.46 | 59.52% | TAX1BP1 | I25 | 7.78 | 49.61% | RP11-397O8.2 | I2 | 7.11 | 20846.39% |
| 40 | FIP1L1 | I18 | 7.27 | 260.75% | MEG3 | I5 | 6.53 | 33.44% | KIAA1107 | I8 | 6.32 | 36.85% | SFPQ | I9 | 5.46 | 69.73% | SLC17A7 | I7 | 7.77 | 20.08% | FAM184B | I16 | 7.10 | 1452.57% |
| 41 | CLDN11 | I11 | 7.19 | 280.79% | ZDHHC11B ZDHHC11 | Ix | 6.53 | 84.02% | GRIA2 | I12 | 6.31 | 23.62% | ANKRD36B | I41 | 5.41 | 106.75% | MASP2 | I8 | 7.77 | 9258.06% | SRPK2 | I30 | 7.04 | 50.73% |
| 42 | SLC6A7 | I4 | 7.18 | 115.35% | EPHX1 RP11-285F7.1 | Ix | 6.52 | 75.49% | SFPQ | I9 | 6.31 | 101.24% | PXK | I19 | 5.40 | 50.57% | AKT3 | I22 | 7.70 | 171.52% | STRBP | I25 | 7.02 | 652.24% |
| 43 | GPR162 | I2 | 7.16 | 93.73% | ACADVL | I9 | 6.52 | 30.48% | GRIA2 | I13 | 6.27 | 22.98% | CUGBP2 | I12 | 5.40 | 51.18% | UBR2 | I21 | 7.68 | 299.60% | VPRBP | I28 | 7.01 | 7800.01% |
| 44 | NCRNA00087 | I3 | 7.14 | 336.91% | EPB41L4A | I23 | 6.52 | 115.29% | CHD8 | I2 | 6.25 | 182.68% | CAMSAP1 | I2 | 5.38 | 221.90% | TBRG1 | I1 | 7.68 | 69.99% | ANKS6 | I3 | 6.99 | 1423.65% |
| 45 | DDX5 | I11 | 7.14 | 21.92% | C14orf45 | I18 | 6.51 | 1903.36% | RP11-154D6.1 | I5 | 6.23 | 303.96% | MLL5 | I25 | 5.38 | 55.18% | SGIP1 | I24 | 7.66 | 166.40% | RP11-539I5.1 | I16 | 6.98 | 680.51% |
| 46 | SRRM2 | I13 | 7.12 | 22.79% | DDX5 | I12 | 6.49 | 22.49% | NHEDC2 | I6 | 6.22 | 208.84% | GRIA2 | I14 | 5.37 | 33.61% | IFT20 | I6 | 7.65 | 146.53% | ARG2 | I6 | 6.98 | 394.00% |
| 47 | MARS | I19 | 7.12 | 98.71% | MOG | I7 | 6.45 | 21.61% | MGEA5 | I12 | 6.21 | 57.95% | ARG2 | I7 | 5.36 | 224.89% | COMMD7 | I8 | 7.62 | 69.61% | AC016831.2 | I3 | 6.97 | 375.23% |
| 48 | LTBP3 | I8 | 7.11 | 85.44% | PLEKHH1 | I8 | 6.43 | 34.51% | GRIA2 | I10 | 6.21 | 22.07% | PDXDC1 | I16 | 5.33 | 182.40% | ANKS6 | I3 | 7.62 | 1169.21% | UBR2 | I21 | 6.92 | 410.17% |
| 49 | GPC1 | I5 | 7.09 | 58.57% | EFCAB2 | I12 | 6.43 | 450.84% | COPG2 | I10 | 6.17 | 56.30% | MEG3 AL117190.2 | Ix | 5.32 | 34.09% | AC016831.2 | I3 | 7.60 | 729.24% | RECK | I11 | 6.91 | 1038.70% |
| 50 | ROGDI | I4 | 7.09 | 35.73% | GNRHR2 | I2 | 6.40 | 5984.93% | RP11-154D6.1 | I4 | 6.17 | 290.68% | NFASC | I29 | 5.31 | 53.26% | CD3EAP | I2 | 7.59 | 1755.25% | RP5-1116C7.1 DNM3 | Ix | 6.90 | 97.69% |
| 51 | PKD1 | I11 | 7.03 | 45.05% | SGMS2 AC096564.3 | Ix | 6.39 | 1551.35% | MRPS22 | I14 | 6.17 | 389.51% | AC018892.5 | I57 | 5.31 | 96.78% | UBE3A | I5 | 7.59 | 74.73% | KIAA1704 | I11 | 6.88 | 364.29% |
| 52 | IFT20 | I6 | 7.02 | 219.81% | C14orf153 | I23 | 6.38 | 34.54% | GRIA2 | I15 | 6.15 | 21.12% | CDK17 | I16 | 5.30 | 74.97% | VPRBP | I28 | 7.57 | 4532.06% | RP1-34B21.1 | I2 | 6.87 | 2328.21% |
| 53 | CENPT | I9 | 7.01 | 78.69% | ROGDI | I4 | 6.36 | 23.40% | SNORD115-26 UBE3A | Ix | 6.15 | 51.05% | PSIP1 | I12 | 5.28 | 46.08% | SNHG6 | I3 | 7.55 | 79.51% | PDXDC1 | I16 | 6.87 | 161.45% |
| 54 | SPTAN1 | I51 | 6.99 | 23.96% | PLEKHH1 | I7 | 6.33 | 32.07% | C16orf72 | I3 | 6.14 | 249.03% | SRPK2 | I30 | 5.28 | 63.29% | TBC1D30 | I14 | 7.53 | 964.73% | AC016910.3 | I1 | 6.86 | 12249.59% |
| 55 | NEIL1 | I7 | 6.99 | 164.14% | RP1-177G6.1 | I3 | 6.31 | 61.02% | INPP4A | I31 | 6.13 | 135.08% | RP11-154D6.1 | I5 | 5.28 | 323.32% | ACBD7 | I6 | 7.49 | 98.54% | AC016910.3 | I2 | 6.85 | 12145.13% |
| 56 | SNORA43 NCLP1 | Ix | 6.98 | 647.53% | CD3EAP | I2 | 6.29 | 403.26% | ANKRD10 | I8 | 6.13 | 251.02% | MLL5 SRPK2 | Ix | 5.26 | 50.58% | DIMT1L | I11 | 7.47 | 85.37% | ATXN1 | I12 | 6.83 | 203.67% |
| 57 | IGSF8 | I3 | 6.98 | 25.23% | AC105446.1 TRIM56 | Ix | 6.29 | 270.16% | KCNIP4 | I2 | 6.12 | 61.72% | HNRNPH1 | I4 | 5.26 | 68.24% | SRPK2 | I29 | 7.46 | 59.74% | RASA1 | I11 | 6.83 | 238.37% |
| 58 | SNORD115-26 UBE3A | Ix | 6.97 | 96.65% | AC011466.2 C19orf68 | Ix | 6.29 | 123.01% | SNORD115-26 UBE3A | Ix | 6.11 | 49.89% | SNURF SNRPN | Ix | 5.25 | 37.20% | ARG2 | I6 | 7.44 | 204.19% | RASA1 | I15 | 6.79 | 232.79% |
| 59 | RP11-122G18.1 | I1 | 6.96 | 252.63% | AL096767.2 | I1 | 6.28 | 632.95% | KCNIP4 | I1 | 6.11 | 61.27% | AL592307.1 | I8 | 5.25 | 168.28% | FAM184B | I16 | 7.44 | 972.70% | C19orf2 | I10 | 6.78 | 35.15% |
| 60 | AL592300.3 | I1 | 6.96 | 104.75% | RP11-809C18.2 DIP2C | Ix | 6.28 | 98.73% | AC013268.3 | I2 | 6.11 | 725.25% | AC073479.1 | I3 | 5.24 | 283.20% | CRBN | I7 | 7.43 | 101.24% | CD3EAP | I2 | 6.76 | 728.41% |
| 61 | CCDC65 FKBP11 | Ix | 6.95 | 211.78% | AP000944.1 | I1 | 6.28 | 40.75% | ADD2 | I24 | 6.09 | 68.02% | PTK2 | I39 | 5.23 | 22.82% | RP11-122G18.1 | I1 | 7.42 | 224.52% | LIMCH1 | I26 | 6.74 | 22.91% |
| 62 | DGKZ | I31 | 6.93 | 29.13% | RP4-758J18.2 | I1 | 6.27 | 1019.50% | SNORD115-26 | I78 | 6.07 | 140.45% | RUNDC3A | I11 | 5.20 | 35.56% | EVL | I12 | 7.38 | 30.06% | PRKRA | I5 | 6.67 | 148.81% |
| 63 | DIMT1L | I11 | 6.92 | 179.97% | RP11-288G11.1 | I1 | 6.22 | 125.05% | R3HDM1 | I18 | 6.03 | 32.01% | ANKRD10 | I8 | 5.20 | 249.39% | LRRC7 | I21 | 7.37 | 511.58% | C17orf42 | I2 | 6.65 | 279.57% |
| 64 | GPC1 | I4 | 6.92 | 51.86% | U52111.5 PLXNB3 | Ix | 6.20 | 57.76% | RUNDC3A | I11 | 6.00 | 35.92% | SORBS1 | I20 | 5.19 | 44.59% | AL133345.1 NOP56 | Ix | 7.35 | 130.36% | CPT1B CHKB | Ix | 6.65 | 814.73% |
| 65 | GP1BB AC000086.1 SEPT5 | Ix | 6.92 | 21.21% | PLXNB3 | I2 | 6.20 | 57.69% | SNORD115-26 UBE3A | Ix | 5.99 | 45.78% | UBE2H | I10 | 5.19 | 120.59% | HNRNPL | I7 | 7.35 | 78.20% | CUGBP2 | I6 | 6.65 | 36.19% |
| 66 | NOXA1 | I10 | 6.91 | 182.53% | PXK | I20 | 6.19 | 75.12% | KALRN | I31 | 5.98 | 72.82% | RP11-149B7.3 | I1 | 5.19 | 102.49% | LL22NC03-80A10.2 | I6 | 7.34 | 1185.83% | GNRHR2 | I2 | 6.63 | 10880.95% |
| 67 | NEIL1 | I6 | 6.89 | 153.43% | AC006273.1 | I1 | 6.19 | 1939.23% | ANKRD10 | I5 | 5.98 | 225.96% | ANKRD10 | I5 | 5.19 | 247.31% | PRMT2 | I9 | 7.33 | 174.62% | ID2 | I3 | 6.62 | 58.98% |
| 68 | RP11-245P10.1 | I1 | 6.89 | 1035.94% | MORN1 | I1 | 6.18 | 1323.55% | RP11-347N5.2 | I1 | 5.98 | 129.47% | KCNC2 | I5 | 5.17 | 83.78% | KIAA1107 | I8 | 7.33 | 61.30% | PAK3 | I6 | 6.62 | 52.30% |
| 69 | AC016910.3 | I1 | 6.88 | 19095.00% | NCRNA00087 | I3 | 6.17 | 238.95% | CDK17 | I16 | 5.98 | 71.46% | LRRC37A | I1 | 5.17 | 449.26% | PAK3 | I6 | 7.32 | 38.56% | TOM1L2 AC122129.1 | Ix | 6.60 | 2543.76% |
| 70 | SPTAN1 | I26 | 6.88 | 22.15% | AC107377.1 AC005332.1 | Ix | 6.12 | 42.20% | CUGBP2 | I12 | 5.96 | 34.75% | AC107377.1 AC005332.1 | Ix | 5.17 | 67.43% | SEPT2 | I4 | 7.30 | 34.18% | AIG1 | I13 | 6.58 | 57.07% |
| 71 | ZDHHC11B ZDHHC11 | Ix | 6.88 | 66.20% | AC007255.2 | I2 | 6.06 | 232.22% | RP1-177G6.1 | I3 | 5.96 | 65.53% | HLA-L HCG17 | Ix | 5.15 | 800.70% | R3HDM1 | I24 | 7.27 | 75.45% | CCDC99 | I11 | 6.57 | 344.15% |
| 72 | AKAP8L | I10 | 6.85 | 46.58% | APLNR | I1 | 6.05 | 168.63% | MEG3 AL117190.2 | Ix | 5.95 | 31.81% | C16orf72 | I3 | 5.15 | 245.85% | LIMCH1 | I26 | 7.26 | 40.79% | TBRG1 | I1 | 6.55 | 47.08% |
| 73 | IGSF8 | I4 | 6.83 | 22.76% | C14orf153 | I27 | 6.04 | 27.34% | Z83843.2 | I1 | 5.95 | 293.10% | INPP4A | I31 | 5.14 | 160.01% | RECK | I11 | 7.25 | 842.07% | RASA1 | I22 | 6.55 | 195.78% |
| 74 | SRRM3 | I12 | 6.81 | 99.90% | C14orf45 | I17 | 6.02 | 1349.22% | RP11-450H6.1 | I1 | 5.94 | 1046.22% | SF1 | I3 | 5.13 | 96.49% | RP11-404G16.2 TF | Ix | 7.24 | 83.65% | TAF15 | I7 | 6.54 | 76.73% |
| 75 | FBXL18 | I6 | 6.80 | 332.84% | LIMS2 GPR17 | Ix | 6.02 | 61.74% | COPG2 | I11 | 5.94 | 47.63% | GATS STAG3 CTB-161A2.2 | Ix | 5.13 | 163.89% | MAP7 | I2 | 7.22 | 68.99% | SFRS5 | I5 | 6.53 | 22.24% |
| 76 | CCDC65 | I8 | 6.80 | 271.81% | RP11-122G18.1 | I1 | 6.02 | 148.73% | ARG2 | I7 | 5.93 | 183.67% | ZNF483 | I6 | 5.12 | 37.21% | CGGBP1 | I4 | 7.22 | 677.79% | SNORD115-26 UBE3A | Ix | 6.53 | 52.15% |
| 77 | CABP1 | I1 | 6.79 | 34.07% | AC034193.2 | I1 | 6.01 | 325.67% | SOD2 | I5 | 5.93 | 133.98% | SOD2 | I5 | 5.10 | 182.01% | GSTA4 | I5 | 7.22 | 39.51% | MED12L | I19 | 6.51 | 1567.33% |
| 78 | AC132660.1 CADM2 | Ix | 6.79 | 201.61% | DGKZ | I29 | 6.00 | 25.52% | AKT3 | I22 | 5.93 | 28.73% | MLL5 | I27 | 5.10 | 45.13% | BRUNOL5 | I12 | 7.21 | 41.23% | SGMS2 AC096564.3 | Ix | 6.50 | 1154.26% |
| 79 | MICAL2 | I27 | 6.79 | 48.49% | INF2 | I23 | 5.98 | 43.13% | ARPP-21 | I8 | 5.93 | 89.18% | DNM1 | I9 | 5.10 | 36.00% | RP1-184J9.1 KDM1 | Ix | 7.21 | 152.24% | MLL5 | I22 | 6.50 | 27.97% |
| 80 | CES8 | I13 | 6.77 | 56.64% | CCDC159 | I9 | 5.93 | 242.11% | KCNIP4 | I2 | 5.91 | 53.01% | ACADVL | I10 | 5.09 | 81.59% | SLC44A1 | I19 | 7.20 | 78.72% | SARNP | I11 | 6.49 | 43.97% |
| 81 | ARG2 | I6 | 6.77 | 238.08% | RP11-539I5.1 | I16 | 5.93 | 991.16% | SFRS14 | I9 | 5.91 | 53.68% | CHD2 | I1 | 5.09 | 61.96% | RP1-34B21.1 | I2 | 7.20 | 1718.76% | MLL5 | I29 | 6.47 | 27.47% |
| 82 | NOL7 | I7 | 6.76 | 112.87% | NOL7 | I7 | 5.92 | 93.46% | SORBS1 | I20 | 5.90 | 44.69% | SIK3 | I18 | 5.08 | 77.19% | AC016716.2 CTNNA2 | Ix | 7.19 | 51.56% | RP11-122G18.1 | I1 | 6.47 | 85.27% |
| 83 | RNFT2 | I11 | 6.75 | 150.24% | ACAP3 | I4 | 5.91 | 34.55% | RP11-397O8.2 | I2 | 5.90 | 952.36% | SLC26A10 | I8 | 5.08 | 376.76% | PNMAL2 | I2 | 7.18 | 207.89% | PSIP1 | I18 | 6.46 | 45.08% |
| 84 | CHD5 | I30 | 6.74 | 21.69% | DMPK | I1 | 5.91 | 49.59% | R3HDM1 | I20 | 5.90 | 29.20% | PLEKHH1 | I8 | 5.07 | 30.12% | C14orf153 AL139300.2 | Ix | 7.18 | 25.29% | ZNF493 | I2 | 6.45 | 1083.21% |
| 85 | AC013283.2 | I1 | 6.74 | 91.08% | NUMA1 | I20 | 5.90 | 38.51% | CLDN11 | I11 | 5.90 | 488.25% | PIGC DNM3 | Ix | 5.05 | 42.84% | AAK1 | I23 | 7.17 | 1736.59% | PDE8A | I19 | 6.45 | 63.39% |
| 86 | DPH1 OVCA2 | Ix | 6.72 | 101.24% | IL3RA | I6 | 5.90 | 161.80% | C14orf153 | I23 | 5.87 | 34.94% | NFASC | I30 | 5.05 | 44.30% | RP3-485C17.1 KCNQ5 | Ix | 7.16 | 122.23% | AC122129.4 TOM1L2 | Ix | 6.45 | 273.67% |
| 87 | C16orf52 | I4 | 6.70 | 351.38% | MTCH1 | I11 | 5.89 | 58.09% | H2AFV | I5 | 5.86 | 125.29% | CCDC65 FKBP11 | Ix | 5.04 | 171.46% | PSIP1 | I18 | 7.16 | 70.45% | MLL5 | I28 | 6.42 | 26.52% |
| 88 | NUMA1 | I20 | 6.70 | 47.88% | LSS AP001469.2 | Ix | 5.89 | 141.29% | SFPQ | I11 | 5.86 | 73.84% | RP11-450H6.1 | I1 | 5.04 | 1387.04% | AC133555.7 | I1 | 7.15 | 95.29% | CGGBP1 | I4 | 6.42 | 598.05% |
| 89 | MMP17 | I8 | 6.67 | 58.01% | EPHX1 RP11-285F7.1 | Ix | 5.88 | 47.92% | AC068587.3 | I1 | 5.85 | 92.95% | AC068587.3 | I5 | 5.04 | 78.04% | MSH6 FBXO11 | Ix | 7.15 | 85.11% | BAIAP2 | I15 | 6.41 | 100.13% |
| 90 | AC009060.6 | I2 | 6.66 | 773.02% | BTN3A2 | I11 | 5.87 | 122.50% | SNORD115-26 UBE3A | Ix | 5.85 | 41.37% | PRUNE2 | I24 | 5.04 | 44.79% | CLDN11 | I11 | 7.15 | 191.00% | AGXT2L2 | I2 | 6.40 | 551.52% |
| 91 | MAN2C1 | I17 | 6.66 | 71.33% | AKAP8L | I10 | 5.84 | 35.78% | PNMAL2 | I2 | 5.84 | 254.90% | KIAA1107 | I8 | 5.03 | 40.59% | PSIP1 | I12 | 7.14 | 69.73% | MUM1 | I4 | 6.40 | 153.66% |
| 92 | PKD1P1 | I10 | 6.65 | 147.53% | FBXL18 | I6 | 5.84 | 349.95% | AC058791.2 | I13 | 5.83 | 131.68% | AKT3 | I22 | 5.03 | 21.99% | KIAA1704 | I11 | 7.14 | 237.12% | SORBS2 | I25 | 6.39 | 85.47% |
| 93 | LMTK3 | I1 | 6.65 | 86.92% | C9orf3 | I29 | 5.82 | 275.48% | CUGBP2 | I12 | 5.82 | 31.44% | EPB41L4A | I23 | 5.03 | 142.49% | RP3-388E23.1 AHI1 | Ix | 7.13 | 57.13% | UBE3A | I2 | 6.39 | 47.42% |
| 94 | CES8 | I11 | 6.64 | 51.76% | RTKN | I13 | 5.81 | 57.01% | SNURF SNRPN | Ix | 5.81 | 21.61% | FABP3 | I4 | 5.03 | 74.65% | RASA1 | I15 | 7.12 | 130.39% | NASP | I8 | 6.39 | 97.32% |
| 95 | AC068587.3 | I3 | 6.61 | 81.03% | SEPT8 | I14 | 5.81 | 22.13% | CCPG1 | I5 | 5.80 | 57.50% | ANKRD36B | I20 | 5.02 | 80.77% | SLC26A10 GEFT | Ix | 7.10 | 919.95% | ENAH | I18 | 6.39 | 34.83% |
| 96 | ACAP3 | I4 | 6.61 | 39.66% | AC105446.1 | I2 | 5.80 | 7530.96% | UBE2H | I10 | 5.78 | 125.24% | SAFB2 | I7 | 5.02 | 101.37% | MARS | I19 | 7.10 | 87.74% | PSIP1 | I12 | 6.38 | 42.62% |
| 97 | ZDHHC11B ZDHHC11 | Ix | 6.61 | 54.81% | ZDHHC11B ZDHHC11 | Ix | 5.80 | 50.35% | SNORD115-26 UBE3A | Ix | 5.77 | 39.30% | GRIA2 | I13 | 5.02 | 26.11% | CNPY2 | I3 | 7.10 | 61.32% | C14orf153 | I23 | 6.38 | 31.79% |
| 98 | DGKZ | I33 | 6.60 | 23.17% | MLL5 | I25 | 5.79 | 58.85% | NCRNA00182 | I8 | 5.77 | 117.51% | PLEKHH1 | I21 | 5.01 | 28.95% | KIF1B | I24 | 7.09 | 49.92% | MSH6 FBXO11 | Ix | 6.38 | 113.02% |
| 99 | CRLF3 | I4 | 6.60 | 131.43% | MAP3K10 | I8 | 5.77 | 21.37% | ARPP-21 | I19 | 5.77 | 79.92% | NFASC | I35 | 5.01 | 42.94% | TSPAN16 | I6 | 7.06 | 17227.39% | BRUNOL5 | I12 | 6.37 | 43.48% |
| 100 | TP53BP1 | I30 | 6.59 | 306.52% | TYRO3 | I3 | 5.77 | 34.83% | LUC7L2 | I3 | 5.77 | 91.89% | PDE4DIP | I54 | 5.00 | 51.41% | RASA1 | I11 | 7.05 | 123.65% | HNRNPL | I7 | 6.37 | 99.58% |